Institutional Investors Increase Holdings in Advanced Micro Devices
What happened
A report detailed significant increases in shares of Advanced Micro Devices by several institutional investors. Artemis Investment Management LLP raised its position by 18.3% during the third quarter. Additionally, BlackRock Inc., State Street Corp, and Invesco Ltd. increased their holdings in the semiconductor manufacturer during the second and fourth quarters, respectively.
From themarketsdaily.com
Why it matters
The reported accumulation of shares by major funds suggests strong institutional confidence in Advanced Micro Devices. These capital movements reflect significant investment interest in the semiconductor industry.
From themarketsdaily.com
Who's involved
- AMDSemiconductor manufacturer whose stock saw increased institutional buying.
- Cantor FitzgeraldFinancial services company that provided the research reports on the stock.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
Keep exploring
The entities involved
-
AMD
American multinational semiconductor company
- Semiconductor stocks drove tech rally gains while the Iran war caused surging inflation concerns and boosted crude prices.
- The AI industry is seeing major shifts, with OEMs like Lenovo developing AI PC lineups, while Intel competes with AMD and Qualcomm, and software like Microsoft Power BI leverages AI.
-
Cantor Fitzgerald
American financial services company
Related events
- Cantor Fitzgerald restated an overweight rating for Anteris Technologies Global Corp. on October 8, 2026.
- Cantor Fitzgerald issued a neutral rating and price target, while Sherry Group Inc. significantly increased its share holdings on October 10, 2026.
- Cantor Fitzgerald upgraded BMNR shares to strong-buy on July 1, 2026.
- Cantor Fitzgerald and Royal Bank of Canada updated their ratings and positions regarding Rezolve Ai.
- Cantor Fitzgerald and Citigroup issued rating updates, while MarketBeat reported research notes on Quince Therapeutics.